EQUIPMENT TO MEMBERS OF THE FEMA URBAN SEARCH AND RESCUE TEAMS. WE’LL HAVE MORE ON THIS
STORY IN OUR NEXT HALF HOUR.
>> TEXAS BIOMED IS A LOCAL
NONPROFIT INFECTIOUS DISEASE
FACILITY. IT’S WORKED ON A
LIFESAVING SIDES OF THE
NUMEROUS DISEASES THAT TEXAS BY
MATT HAS WORKED ON THE
ORGANIZATIONS. COVID WORK
ACTUALLY HELPED DEVELOP
PFIZER’S VACCINE AS WELL AS
KEY THERAPEUTICS. RIGHT NOW,
TEXAS BIOMED IN THE MIDST IN
YEAR 2 OF A 10 YEAR STRATEGIC
GROWTH PLAN. AND THAT’S
EXPECTED TO BE 3.2 BILLION
DOLLAR IMPACT OUR LOCAL
ECONOMY. JOINING US IN TODAY’S
LEADING SA SEGMENT IS DOCTOR
LARRY SCHLESINGER.
>> PRESIDENT CEO OF TEXAS
BIOMED, THANK YOU SO MUCH FOR
JOINING US. DOCTOR.
>> BUT PLEASURE TO JOIN YOU
THIS MORNING.
>> WELL, FIRST AND FOREMOST, IT
REALLY IS AMAZING TO THINK THAT
COMPONENTS OF THE COVID VACCINE
WERE DEVELOPED RIGHT HERE IN
SAN ANTONIO AS WELL AS ANTIBODY
TREATMENTS. NO, FROM YOUR
PERSPECTIVE, WHAT THAT PROCESS
LOOK LIKE.
>> RIGHT. I IT’S IMPORTANT TO
KNOW THAT ANY SHOT HERE THERAPY
THAT’S DEVELOPED HAS A LOT
BEHIND IT IN THE SO-CALLED
PRECLINICAL SPACE. AND THAT IS
REALLY A LOT OF SCIENCE THAT
GETS US TO NEW DISCOVERIES THAT
REALLY MAKE AN IMPACT ON
TERROR. PEACE AND VACCINES IS A
TEXAS BIOMED BASED ON OUR
MISSION OF PROTECTING YOU, YOUR
FAMILIES AND THE GLOBAL
COMMUNITY FROM THE SPREAD OF
INFECTIOUS DISEASES LEAD IN
EARLIER IS ALMOST 2 YEARS AGO.
NOW IN FEBRUARY OF AND REALLY
DECIDED WITHIN A DAY OR 2 THAT
OUR IMPACT WAS GOING TO BE IN
DEVELOPING THESE PRECLINICAL
ANIMAL MODELS TO ENABLE
THERAPIES AND VACCINES TO COME
AND WITH COMMUNITY A LOT OF
CONTRIBUTIONS TO THE U.S. TO
WATCH STAR ANIMAL STUDIES CITY
2 MONTHS VALIDATED THOSE ANIMAL
STUDIES. AND THAT’S WHAT
ENABLED EARLY ON FOR US TO
INTERACT WITH PFIZER-BIONTECH
WITH A REGENERON AND NOVAVAX
AND BEGIN THOSE STUDIES IN THE
LATE SPRING OF 20. IT WAS A
SUCCESS IN THOSE ANIMAL MODELS
THAT RESEMBLED THE SUCCESS FOR
SAVING HIM. IT’S THAT ENABLE
THOSE CLINICAL STUDIES TO BEGIN
IN THE SUMMER OF 2020. AND IT’S
HARD TO BELIEVE THAT THE PFIZER
BIONTECH TAKE THE VACCINE THAT
TICKS BY MAJID. ALL THE WORK ON
HAS NOW BEEN A IT
ADMINISTRATION TO HUMANS,
ALMOST HALF A BILLION OF THOSE
VACCINES HAVE BEEN DISTRIBUTED
A VERY, VERY PROUD OF THAT
ACCOMPLISHMENT ALONE.
>> A BIG ACCOMPLISHMENT INDEED.
SO JUST THIS WEEK, TEXAS BIOMED
BROKE GROUND ON A NEW
FACILITIES. SO WHAT MAKES IT SO
IMPORTANT? WHAT CAN PEOPLE
EXPECT?
>> WELL, YOU KNOW, WE HAVE AN
80 YEAR-OLD CAMPUS AND WE ARE
IN OUR 10 YEAR STRATEGIC PLAN.
AND ANIMAL CARE COMPLEX IS THE
FIRST MAJOR CAPITAL PROJECT OF
OUR 10 YEAR STRATEGIC PLAN,
WHICH WE REALLY WERE GOING TO
DO A REDO OF THE CAMPUS.
THIS IS AN AMAZING PROJECT IN
THE SOUTH OF THE CAMPUS.
IT’S REALLY FOR BUILDINGS,
18,000 SQUARE FEET OF SPACE.
AND IT’S GOING TO ENABLE US
TO GREATLY EXPAND WHAT IS A
NATIONAL AND GLOBAL SHORTAGE.
AND THAT IS NON
HUMAN PRIMATES. BUT HELP US GET
TO DO THERAPY. SHOULD VACCINES
WILL BE ABLE TO MISSUS 1000?
NEW PRIMATES WILL ALSO HAVE A
NEW VETERINARY HOSPITAL WHERE
REALLY ARE 100, 50 EMPLOYEES.
ARE THE AREAS ARE BEHAVIOR
LIZARD THAT TEXT OF THE CARE
TAKERS CAN COME TOGETHER AND
DELIVER STATE OF THE ART HUMANE
CARE OF THOSE AS WE WORK WITH
THEM TO ACHIEVE GREAT THAT
HELPS THIS IS GOING TO BE 4
IT WAS LAUNCHED BY ACTUALLY A
FEDERAL GRANT FROM ECONOMIC
DEVELOPMENT ADMINISTRATION.
AND THEN IT GET GENEROUS
DONATIONS BY DONORS IN THE
COMMUNITY AS WELL AS TO SHARE
RESOURCES THAT ENABLE US TO
BUILD THIS BUILDING. THIS IS
REALLY JUST THE START OF
SEVERAL OF OUR CAPITAL
PROJECTS. STAY TUNED. OUR
CENTRAL RESEARCH BUILDING,
WHICH WOULD BE OUR NEW FRIEND
OR BUILDING IS REALLY WHAT
WE’RE ON. DEVELOPING RISA
SOURCES FOR NOW. YOU KNOW,
THESE ARE, CHANGING
OPPORTUNITIES FOR THE INSTITUTE
IN SAN ANTONIO.
>> AND GAME CHANGING 100%.
SO THE QUESTION IS NOT ONLY FOR
SAN ANTONIO, BUT FOR YOU GUYS.
WHAT IS THE FUTURE OF BY TEXAS
BIOMED? WHAT IS THE FUTURE OF
THE BIOMEDICAL INDUSTRY HERE
LOCALLY? LOOK LIKE I MEAN, WHEN
IT COMES TO JOBS, EDUCATION
AND BLAKE, YOU ALLUDED TO
SCIENTIFIC BREAK, THURS.
>> WELL, I WITH REGARD TO LET’S
START WITH TEXAS I THINK YOU’RE
GOING TO SEE CONTINUED GROWTH
IS STRATEGIC PLAN, AS YOU
MENTIONED AT THE THIS IS A
TREMENDOUS ECONOMIC DEVELOPMENT
PLAN FOR THE WE’RE TALKING
ABOUT MOVING FROM JUST UNDER
400 CURRENT EMPLOYEES TO 700
EMPLOYEES IS OUR HIGH WAGE
EARNING JOBS. WE ANTICIPATE OUR
PLAN WILL BRING IN ABOUT 1700
NEW EITHER DIRECTLY OR
INDIRECTLY, TO THE EXTENT AND I
THINK IT’S A GREAT OPPORTUNITY.
THERE ARE 3 THINGS I’D
EMPHASIZE ABOUT TEXAS BIOMED IN
TERMS OF BESIDES THE SCIENCE
AND ART GROWTH FOR THE FUTURE
AND THAT IS ECONOMIC
DEVELOPMENT. WE JUST MENTIONED
IT’S EDUCATION. AND, YOU KNOW,
CURRENTLY WE HAVE ABOUT 10,000
STUDENTS THAT WE INTERACT WITH
IN SAN ANTONIO IN ALL 17 SCHOOL
DISTRICT’S FIRST. WE HAVE
INTERNSHIPS EXTRA CHIP STUDENTS
ON CAMPUS. WE DO OUTREACH.
IT’S A VERY IMPORTANT PART OF
TEXAS. BIOMED AND THEN IT’S OUR
CONNECTION WITH THE MILITARY.
WE HAVE A FORMAL AGREEMENT WITH
THE 59TH MEDICAL WING WE’RE
WE SOLDIERS IN RESEARCH.
CURRENTLY WE HAVE GRANTS WITH
THE MILITARY AND WE EXPECT TO
EXPAND THAT. AND THEN FINALLY,
IT’S THE CULTURE OF SAN ANTONIO
THE 4 PRESIDENTS OF THE MAJOR
RESEARCH ORGANIZATIONS IN WE
SPEAK FREQUENTLY. WE HAVE
COLLABORATIVE RESEARCH
ARRANGEMENTS. IT’S ABOUT
EXPLOITING ALL THE TALENT
RESOURCES. SAN ANTONIO HAS TO
BEAR. AND THAT IS ABOUT TELLING
THE WORLD ABOUT WE’RE NOT A
SECRET WERE ACTUALLY A GREAT
ECONOMIC ENGINE FOR THE FUTURE
IN BY MEDICAL SCIENCE AND
HEALTH CARE. AND I THINK OUR
FUTURE IS VERY BRIGHT AND KEY.
>> WELL, DOCTOR SCHLESINGER,
THANK YOU SO MUCH FOR YOUR
TIME. AND ALL OUR VIEWERS
WATCHING. IF YOU WANT TO SEE
THIS FULL INTERVIEW, JUST HEAD